Walleye Trading LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$69.02 - $93.84 $213,962 - $290,904	-3,100 Reduced 11.31%	24,300 $1.71 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $1.21 Million - $1.49 Million	16,200 Added 144.64%	27,400 $2.26 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $427,431 - $504,900	-5,100 Reduced 31.29%	11,200 $978,000
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $137,196 - $177,318	1,800 Added 12.41%	16,300 $1.57 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $2.62 Million - $2.91 Million	-30,800 Reduced 67.99%	14,500 $1.28 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $1.16 Million - $1.34 Million	13,400 Added 42.01%	45,300 $3.93 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $886,174 - $1.18 Million	-10,100 Reduced 24.05%	31,900 $3.1 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $396,557 - $532,287	4,900 Added 13.21%	42,000 $4.35 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $2.2 Million - $2.6 Million	26,800 Added 260.19%	37,100 $3.15 Million
Q2 2022 Aug 08, 2022	SELL	$71.48 - $86.85 $378,844 - $460,304	-5,300 Reduced 33.97%	10,300 $854,000
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $906,216 - $1.13 Million	12,200 Added 358.82%	15,600 $1.2 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $1.89 Million - $2.41 Million	-26,400 Reduced 88.59%	3,400 $300,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $119,632 - $136,752	-1,600 Reduced 5.1%	29,800 $2.3 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $1.08 Million - $1.21 Million	14,300 Added 83.63%	31,400 $2.62 Million
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $769,719 - $934,107	10,300 Added 151.47%	17,100 $1.29 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $1.44 Million - $1.79 Million	-19,900 Reduced 74.53%	6,800 $596,000
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $1.03 Million - $1.87 Million	14,300 Added 115.32%	26,700 $2.03 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $119,325 - $186,330	1,500 Added 13.76%	12,400 $1.53 Million
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $199,836 - $271,180	2,800 Added 34.57%	10,900 $921,000
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $1.2 Million - $1.61 Million	-18,600 Reduced 69.66%	8,100 $685,000
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $1.73 Million - $2.19 Million	-25,700 Reduced 49.05%	26,700 $1.8 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $2.65 Million - $3.1 Million	33,000 Added 170.1%	52,400 $4.49 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $850,420 - $996,062	10,100 Added 108.6%	19,400 $1.72 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $456,798 - $604,599	-5,700 Reduced 38.0%	9,300 $792,000
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $657,440 - $740,040	7,000 Added 87.5%	15,000 $1.46 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $364,848 - $475,344	4,800 Added 150.0%	8,000 $754,000
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $147,573 - $175,997	1,900 Added 146.15%	3,200 $259,000
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $80,600 - $94,950	1,000 Added 333.33%	1,300 $121,000
Q2 2017 Aug 14, 2017	BUY	N/A	300	300 $27,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.51 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.25 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$921 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$696 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account